Student Posters 51st Lorne Proteins Conference 2026

AI-designed protein inhibitors can block hemoglobin binding and inhibit growth of pathogenic E. coli (#123)

Daniel R. Fox 1 2 3 , Kazem Asadollahi 2 , Imogen Samuels 2 , Bradley A. Spicer 4 , Ashleigh Kropp 1 2 3 , Christopher J. Lupton 4 , Kevin Lim 5 , Chunxiao Wang 2 , Hari Venugopal 6 , Marija Dramicanin 5 7 , Gavin Knott 8 , Rhys Grinter 1 2 3
  1. Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, Australia
  2. Department Of Biochemistry and Pharmacology , Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia
  3. Centre for Electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia
  4. Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
  5. The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
  6. Ramaciotti Centre for Cryo-Electron Microscopy, Biomedicine Discovery Institute, Monash University , Clayton, Victoria, Australia
  7. Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia
  8. Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia

Iron, an essential nutrient for most bacteria, is often a limiting nutrient during infection, due to the host sequestering free iron as part of the innate immune response. To obtain the iron required for growth, many bacterial pathogens encode proteins capable of extracting the iron-containing cofactor heme directly from host proteins. Pathogenic E. coli and Shigella spp. produce the outer membrane transporter ChuA, which binds host hemoglobin and extracts its heme cofactor, before importing heme into the cell. Heme extraction by ChuA is a dynamic process, with the transporter capable of rapidly extracting heme from hemoglobin in the absence of an external energy source, and without forming a stable ChuA-hemoglobin complex. In this work, we utilise a combination of structural modelling, Cryo-EM, X-ray crystallography, mutagenesis, spectroscopy and phenotypic analysis to understand the mechanistic detail of this process. Based on this understanding we utilise artificial intelligence-based protein design to create binders capable of inhibiting E. coli growth by blocking hemoglobin binding to ChuA. By screening a limited number of these designs, we identify several binders that inhibit E. coli growth at low nanomolar concentrations, without further optimisation. We determine the structure of a subset of these binders, alone and in complex with ChuA, demonstrating that they closely match the computational design. This work demonstrates the utility of de novo-designed proteins for inhibiting bacterial membrane transporters and uses a workflow that could equally be applied to integral membrane proteins in other organisms or pathogens.

 

Associated reference:

Fox, D. R., Asadollahi, K., Samuels, I., Spicer, B. A., Kropp, A., Lupton, C. J., Lim, K., Wang, C., Venugopal H., Dramicanin, M., Knott, G.#, Grinter, R.# Inhibiting heme-piracy by pathogenic Escherichia coli using de novo-designed proteins. Nature Communications, (2025).